Navigation Links
Clinical Trial Demonstrates That EarlySense May Be An Effective Indicator for Respiratory Pattern Recognition
Date:1/13/2014

WALTHAM, Mass., Jan. 13, 2014 /PRNewswire/ -- EarlySense, the market leader in Proactive Patient Care Solutions, announced today the results of a small clinical trial conducted at Brigham and Women's Hospital in Boston that identifies complex respiratory patterns which were found to be correlated to patients' respiratory condition and have the potential to show when mechanical ventilation is no longer required.

"The study results show that unique, complex respiratory patterns have the potential to predict, on one hand, the patients' readiness to be separated from the ventilator, but, alternately, also the need for continued ventilatory support," said Dr. Gyorgy Frendl, MD, PhD, Director of Surgical Critical Care Research, Brigham and Women's Hospital, Assistant Professor of Anesthesia, Harvard Medical School, the Principal Investigator of the study. "For patients recently weaned from the ventilator, the appearance of these complex distress respiratory patterns indicated that they were likely to require further ventilator support:

  • Generalized disorganized respirations
  • Frequent [every 30-120 seconds] high amplitude gasping breaths
  • Periods of apnea >30 seconds

For ventilated patients, the above patterns indicated that the patient is not yet ready to be separated from the mechanical ventilator support.

"The ability to measure advanced respiratory patterns in a contact-free manner is a promising approach to improve care and keep patients safer," said Avner Halperin, CEO of EarlySense. We are honored that the EarlySense technology can determine respiratory patterns and provide clinicians with advanced tools to intervene effectively and, if required, early as evidenced in this study."

About EarlySense
EarlySense has brought to market an innovative technology designed to advance proactive patient care and empower clinicians to achieve better patient outcomes. Through early detection, the EarlySense system assists clinicians in identifying and preventing potential adverse events. It does so by providing motion rates and bed exit alarms, to help reduce falls and pressure ulcers, as well as surveillance of heart and respiratory rates to potentially detect patient deterioration. The company's flagship product, the EarlySense System, is a continuous, contact-free, patient safety monitoring solution that monitors and documents a patient's vital signs and movement using a sensor that is placed underneath a bed mattress. There are no leads or cuffs to connect to the patient who has complete freedom of movement and is not burdened by any cumbersome attachments. The system was designed to monitor patients on medical surgical floors who are usually monitored by nursing staff approximately once every four hours. The system is currently installed at hospitals and rehabilitation centers in the USA and Europe. It is also commercially available in Canada. Hospital administrators report that patients, their families and staff feel more comfortable knowing the system is in place. EarlySense Inc. is headquartered in Waltham, MA. 

Follow us on Twitter.
Like us on Facebook.


'/>"/>
SOURCE EarlySense
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CRLX101 Meets Primary Endpoint in Phase 2 Clinical Trial in Relapsed Ovarian Cancer
2. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
3. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
4. EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
5. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
6. Kaiser Permanente-Led Team to Become Integral Part of New National Clinical Research Network
7. Rigel Will Present Clinical Product Portfolio Update at J.P. Morgan Healthcare Conference
8. Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa for distal ulcerative colitis
9. Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
10. Croissance Clinical Research Collaborates with Acceliant for Clinical Trial Excellence
11. BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):